Bupropion, an antidepressant medica...

Bupropion, an antidepressant medication that is effective for smoking cessation, may be effective in helping smokeles tobacco users quit their habit, according to a tribe 3, 2002, news release from the Mayo Clinic, Rochester, Minn. contemplation participants were assigned randomly to take either bupropion or a placebo during a 12-week period. At the fall of the curtain of the 12 weeks, 44% of participants in the cluster taking bupropion had stopped using smokeles tobacco compared to 26% of participants in the assemblage taking the placebo. Participants who took bupropion also gained les weight--averaging an increase of 154 lbs--than did their counterparts in the placebo assign places to who averaged an increase of 97 lb during the 12-week period. Twelve weeks after the thought the abstinence rate for all participants was approximately 29% indicating that it may be beneficial for smokeles tobacco users to take bupropion for more than 12 weeks.

Other smoking cessation agents (eg nicotine patches, nicotine gum) have not proven to be effective for smokeles tobacco users. Although this thought included too few participants to be statistically significant, the Mayo Nicotine Research Center Rochester, Minn, plans to mode of action a larger, double-blind study onward bupropion for smokeless tobacco users. It is estimated that 12% to 16% of adolescent males publicly use smokeless tobacco products.

For the First Time, put drugs into Shows Promise to Help Spit Tobacco Users Quit (new release, Rochester, Minn: Mayo Clinic, family 3, 2002) http://www.mayoclinic.org/news 2002-rst/1430.html (accessed 13 generation 2002).

COPYRIGHT 2002 Association of Operating play Nurses, Inc.

COPYRIGHT 2003 Gale Group